Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Lohr

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Human Pathology|September 27, 2014
No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) statusElena-Sophie Prigge, Katharina Urban, Sandrine Stiegler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 7, 2018
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRTJudit Boda-Heggemann, Anika Jahnke, Mark K H Chan, et al.
Acta Oncologica (Stockholm, Sweden)|April 5, 2023
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysisConstantin Dreher, Gustavo R Sarria, Georgia Miebach, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterationsJudit Boda-Heggemann, Anika Jahnke, Mark K H Chan, et al.
Cancers|January 21, 2023
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS StudySalvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
Clinical Lung Cancer|October 24, 2018
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter AnalysisVieri Scotti, Alessio Bruni, Giulio Francolini, et al.
Blood Advances|January 4, 2018
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamideFranco Aversa, Esther Bachar-Lustig, Noga Or-Geva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 5, 2018
Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy - An international multi-center validation for prostate cancerBen Heijmen, Peter Voet, Dennie Fransen, et al.
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Human Pathology|September 27, 2014
No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) statusElena-Sophie Prigge, Katharina Urban, Sandrine Stiegler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 7, 2018
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRTJudit Boda-Heggemann, Anika Jahnke, Mark K H Chan, et al.
Acta Oncologica (Stockholm, Sweden)|April 5, 2023
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysisConstantin Dreher, Gustavo R Sarria, Georgia Miebach, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterationsJudit Boda-Heggemann, Anika Jahnke, Mark K H Chan, et al.
Cancers|January 21, 2023
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS StudySalvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
Clinical Lung Cancer|October 24, 2018
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter AnalysisVieri Scotti, Alessio Bruni, Giulio Francolini, et al.
Blood Advances|January 4, 2018
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamideFranco Aversa, Esther Bachar-Lustig, Noga Or-Geva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 5, 2018
Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy - An international multi-center validation for prostate cancerBen Heijmen, Peter Voet, Dennie Fransen, et al.
Cancers|June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
Pageof 15